Our long-term goal is to induce a regulatory T cell (Treg) response following traumatic brain injury TBI and enhance the neuroprotective effects with cell-directed vascular endothelial growth factor (VEGF)- nanoformulations. We hypothesize that T cell targeted delivery of VEGF-nanoformulations will provide synergistic protection to both the injured vasculature and parenchyma. TBI initiates a complicated biochemical cascade that includes a strong neuroinflammatory component. Treg can infiltrate the brain in response to injury and control the inflammatory response. Granulocyte macrophage colony stimulating factor (GM-CSF), can induce a potent Treg response and provide neuroprotection. To augment this neuroprotective response, we propose loading these cells with VEGF to stimulate regeneration of neurons and endothelium. VEGF induces angiogenesis and neurogenesis and can reduce morbidities after experimental brain injury. However, systemic administration of VEGF is problematic and requires targeted delivery. We propose a two-step experimental approach. First, we will induce a neuroprotective T cell response and second use that induction to carry VEGF to the brain. We propose 3 specific aims utilizing a combination of in vitro and in vivo trauma models with supporting biochemical, neuroimaging, behavioral and targeted drug delivery methods.
In Specific Aim 1, we will produce VEGF-nanoformulations with anionic block copolymers and will test these complexes for biological effect in vitro and in vivo.
In Specific Aim 2, we will characterize the effect of GM-CSF following trauma. Neuroprotective outcomes will be evaluated by immunohistochemical detection of glia and neuronal markers, morphologic determination of the lesion size, and behavioral tests.
In Specific Aim 3, we will determine the rate of in vitro uptake and release of the VEGF nanoformulations in Treg. In this aim, we will utilize bioimaging, behavior, and histology to determine , outcomes following treatment with T cell directed VEGF-nanoformulations. This research is an essential first step to developing and delivering novel nanotherapeutics for the treatment of clinical TBI.
Traumatic brain injury (TBI) causes neuronal cell death, cerebrovascular damage, and inflammation. Regulatory T cells infiltrate areas of damage to control inflammation and may also be used to deliver nanoformulated vascular endothelial growth factor to induce regeneration of damaged tissue. We will test this strategy using in vitro and in vivo trauma models with biochemical, neuroimaging, and behavioral methods. This strategy could provide a synergistic combination therapy for TBI.
|Saraswathi, Viswanathan; Ganesan, Murali; Perriotte-Olson, Curtis et al. (2016) Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity. Biochem Biophys Res Commun 469:495-500|
|Mahajan, Vivek; Gaymalov, Zagit; Alakhova, Daria et al. (2016) Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers. Biomaterials 75:58-70|
|Xie, Ying; Wehrkamp, Cody J; Li, Jing et al. (2016) Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness. Mol Pharm 13:1073-80|
|Fan, Wei; Shi, Wen; Zhang, Wenting et al. (2016) Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer. Biomaterials 103:101-15|
|Perriotte-Olson, Curtis; Adi, Nikhil; Manickam, Devika S et al. (2016) Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesity. Obesity (Silver Spring) 24:148-56|
|Jiang, Jiang; Li, Zhuoran; Wang, Hongjun et al. (2016) Expanded 3D Nanofiber Scaffolds: Cell Penetration, Neovascularization, and Host Response. Adv Healthc Mater 5:2993-3003|
|Raja, Srikumar M; Desale, Swapnil S; Mohapatra, Bhopal et al. (2016) Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition. Oncotarget 7:10522-35|
|Mahajan, Vivek; Gaymalov, Zagit; Alakhova, Daria et al. (2016) Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers. Data Brief 7:1269-82|
|Jiang, Yuhang; Brynskikh, Anna M; S-Manickam, Devika et al. (2015) SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. J Control Release 213:36-44|
|Wakaskar, Rajesh R; Bathena, Sai Praneeth R; Tallapaka, Shailendra B et al. (2015) Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after I Pharm Res 32:1028-44|
Showing the most recent 10 out of 59 publications